Telemedicine-Based Postoperative Follow-up After Cataract Surgery: A Randomized Controlled Trial (TELE-CAT Study)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20260710001

Enrollment

290

Registered

2026-07-10

Start date

2026-07-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing uncomplicated cataract surgery requiring postoperative follow-up for detection of postoperative complications and monitoring of visual outcomes Cataract

Interventions

145 subjects are in the Telemedicine follow-up group.,145 subjects are in the Conventional follow-up group.

Experimental Procedure/Surgery,Active Comparator Procedure/Surgery

telemedicine,conventional

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Undergoing uncomplicated cataract surgery by phacoemulsification with implantation of a foldable intraocular lens and no intraoperative complications. 2. Able to access communication devices or technologies required for telemedicine follow up, including video calls or online communication systems. 3. Able to communicate adequately in Thai or English. 4. Willing and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Presence of intraoperative or postoperative complications requiring close clinical follow up, including posterior capsule rupture, vitreous loss, or acute postoperative endophthalmitis. 2. Ocular or systemic diseases that may significantly affect visual outcomes or require specialized follow up care, including advanced glaucoma, severe diabetic retinopathy, uveitis, or monocular status. 3. Medical conditions associated with increased risk of postoperative complications or limitations in telemedicine use, including uncontrolled diabetes mellitus, immunodeficiency, immunosuppressive therapy, unstable cardiovascular disease, advanced chronic respiratory disease, end stage renal disease, severe chronic liver disease, frailty, or unstable psychiatric illness. 4. Communication limitations, including physician diagnosed dementia or significant hearing or speech impairment affecting communication with healthcare providers.

Design outcomes

Primary

Measure	Time frame
Efficacy from day 1- day 60 postoperative period visual acuity	—

Secondary

Measure	Time frame
Safety from day 1- day 60 postoperative period endophthalmitis rate,Satisfaction at postoperative follow up day questionnaires	—

Countries

Thailand

Contacts

Public ContactRaveewan Choontanom

Phramongkutklao College of Medicine

r.choontanom@gmail.com0917891464

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026